# Immune-Mediated Pathophysiology And Clinical Triage Program

> **NCT04354649** · PHASE2 · RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 46 (estimated)

## Conditions studied

- Arthritis
- Arthralgia

## Interventions

- **DRUG:** Hydroxychloroquine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04354649
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-16
- **Primary completion:** 2026-07
- **Final completion:** 2029-07
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04354649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04354649, "Immune-Mediated Pathophysiology And Clinical Triage Program". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04354649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*